Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.16.711857

Linking Codon- and Protein-Level Mutation Scores to Population Genetics Reveals Heterogeneous Selection Efficiency Across Escherichia coli Lineages

Abstract

Quantifying the selective effects of individual mutations is essential to understand how their population-wise frequencies evolve under natural selection and genetic drift. Large genomic datasets provide a real-life experiment that we exploit to characterize the efficiency of selection across different mutations types and populations. Using Direct Coupling Analysis, a model from statistical physics, we derive protein-informed scores for individual non-synonymous mutations identified in 81,440 Escherichia coli genomes. We show that these scores act as a latent variable capturing the probability that a mutation is beneficial, neutral, or mildly to highly deleterious. We contribute to the debate on the importance of synonymous mutations by demonstrating that their selection intensities span a single order of magnitude in the E. coli species, whereas non-synonymous mutations span six orders of magnitude. We further relate selection efficiency to genetic drift, defined as the inverse of population size, and to ecological lifestyle, and we identify a 10,000-fold reduction in selection efficiency between the entire E. coli species and its most pathogenic populations. Together, these results highlight how population genetics and protein variant fitness predictors inform one another: variation in selection efficiency is associated with shifts in the distribution of mutation scores, and population genetics data provide a benchmark to assess the accuracy of these scores. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=182 SRC="FIGDIR/small/711857v1_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@c9f62borg.highwire.dtl.DTLVardef@140b8d9org.highwire.dtl.DTLVardef@27cf00org.highwire.dtl.DTLVardef@18722b9_HPS_FORMAT_FIGEXP M_FIG Schematic representation of the analysis of polymorphism in 81,440 Escherichia coli genomes. 458,443 polymorphic codon sites were identified and oriented using homologous sequences from closely related species. Mutations can be classified as synonymous or non-synonymous based on whether they alter the amino-acid sequence encoded, and real-valued scores predictive of fitness effects can be attributed to mutations within each of these classes. Codon scores reflect the global codon usage preference within the E. coli genome. DCA scores capture position- and amino-acid-specific preference as well as epistatic constraints and are obtained for each protein from a set of distantly related homologous sequences. Coupled with the abundance of polymorphic sites within different E. coli subpopulations, these different polymorphism classifications allow to precisely compare the intensity of selection between different types of mutations and across populations with distinct lifestyles, illustrated here by their pathogenic power. C_FIG

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mischler, M., Vigue, L., Croce, G., Weigt, M., Tenaillon, O.. 2026-03-18. Linking Codon- and Protein-Level Mutation Scores to Population Genetics Reveals Heterogeneous Selection Efficiency Across Escherichia coli Lineages. https://doi.org/10.64898/2026.03.16.711857

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗